130 related articles for article (PubMed ID: 16386417)
1. Discovery and optimization of a novel series of liver X receptor-alpha agonists.
Li L; Liu J; Zhu L; Cutler S; Hasegawa H; Shan B; Medina JC
Bioorg Med Chem Lett; 2006 Mar; 16(6):1638-42. PubMed ID: 16386417
[TBL] [Abstract][Full Text] [Related]
2. Induction of intestinal ATP-binding cassette transporters by a phytosterol-derived liver X receptor agonist.
Kaneko E; Matsuda M; Yamada Y; Tachibana Y; Shimomura I; Makishima M
J Biol Chem; 2003 Sep; 278(38):36091-8. PubMed ID: 12847102
[TBL] [Abstract][Full Text] [Related]
3. The effect of T0901317 on ATP-binding cassette transporter A1 and Niemann-Pick type C1 in apoE-/- mice.
Dai XY; Ou X; Hao XR; Cao DL; Tang YL; Hu YW; Li XX; Tang CK
J Cardiovasc Pharmacol; 2008 May; 51(5):467-75. PubMed ID: 18437096
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and SAR of potent LXR agonists containing an indole pharmacophore.
Washburn DG; Hoang TH; Campobasso N; Smallwood A; Parks DJ; Webb CL; Frank KA; Nord M; Duraiswami C; Evans C; Jaye M; Thompson SK
Bioorg Med Chem Lett; 2009 Feb; 19(4):1097-100. PubMed ID: 19167885
[TBL] [Abstract][Full Text] [Related]
5. [Synthesis of (24S)-hydroxy- and (24S)-24,25-epoxycholesterol analogues, potential agonists of nuclear LXR receptors].
Khripach VA; Zhabinskiĭ VN; Antonchik AV; Antonchik AP
Bioorg Khim; 2006; 32(6):651-9. PubMed ID: 17180916
[TBL] [Abstract][Full Text] [Related]
6. Ligand specificity and evolution of liver X receptors.
Reschly EJ; Ai N; Welsh WJ; Ekins S; Hagey LR; Krasowski MD
J Steroid Biochem Mol Biol; 2008 May; 110(1-2):83-94. PubMed ID: 18395439
[TBL] [Abstract][Full Text] [Related]
7. T0901317 is a dual LXR/FXR agonist.
Houck KA; Borchert KM; Hepler CD; Thomas JS; Bramlett KS; Michael LF; Burris TP
Mol Genet Metab; 2004; 83(1-2):184-7. PubMed ID: 15464433
[TBL] [Abstract][Full Text] [Related]
8. Combination of virtual screening and high throughput gene profiling for identification of novel liver X receptor modulators.
Cheng JF; Zapf J; Takedomi K; Fukushima C; Ogiku T; Zhang SH; Yang G; Sakurai N; Barbosa M; Jack R; Xu K
J Med Chem; 2008 Apr; 51(7):2057-61. PubMed ID: 18324758
[TBL] [Abstract][Full Text] [Related]
9. Liver X receptors (LXR) as therapeutic targets in dyslipidemia.
Bełtowski J
Cardiovasc Ther; 2008; 26(4):297-316. PubMed ID: 19035881
[TBL] [Abstract][Full Text] [Related]
10. Discovery and Optimization of a Series of Sulfonamide Inverse Agonists for the Retinoic Acid Receptor-Related Orphan Receptor-α.
Doebelin C; He Y; Campbell S; Nuhant P; Kumar N; Koenig M; Garcia-Ordonez R; Chang MR; Roush WR; Lin L; Kahn S; Cameron MD; Griffin PR; Solt LA; Kamenecka TM
Med Chem; 2019; 15(6):676-684. PubMed ID: 30799793
[TBL] [Abstract][Full Text] [Related]
11. A nuclear receptor corepressor-dependent pathway mediates suppression of cytokine-induced C-reactive protein gene expression by liver X receptor.
Blaschke F; Takata Y; Caglayan E; Collins A; Tontonoz P; Hsueh WA; Tangirala RK
Circ Res; 2006 Dec; 99(12):e88-99. PubMed ID: 17110595
[TBL] [Abstract][Full Text] [Related]
12. X-ray crystal structure of the liver X receptor beta ligand binding domain: regulation by a histidine-tryptophan switch.
Williams S; Bledsoe RK; Collins JL; Boggs S; Lambert MH; Miller AB; Moore J; McKee DD; Moore L; Nichols J; Parks D; Watson M; Wisely B; Willson TM
J Biol Chem; 2003 Jul; 278(29):27138-43. PubMed ID: 12736258
[TBL] [Abstract][Full Text] [Related]
13. Liver X receptor activator downregulates angiotensin II type 1 receptor expression through dephosphorylation of Sp1.
Imayama I; Ichiki T; Patton D; Inanaga K; Miyazaki R; Ohtsubo H; Tian Q; Yano K; Sunagawa K
Hypertension; 2008 Jun; 51(6):1631-6. PubMed ID: 18443233
[TBL] [Abstract][Full Text] [Related]
14. Liver X receptor agonist T0901317 reduces atherosclerotic lesions in apoE-/- mice by up-regulating NPC1 expression.
Ou X; Dai X; Long Z; Tang Y; Cao D; Hao X; Hu Y; Li X; Tang C
Sci China C Life Sci; 2008 May; 51(5):418-29. PubMed ID: 18785587
[TBL] [Abstract][Full Text] [Related]
15. Ligand, receptor, and cell type-dependent regulation of ABCA1 and ABCG1 mRNA in prostate cancer epithelial cells.
Trasino SE; Kim YS; Wang TT
Mol Cancer Ther; 2009 Jul; 8(7):1934-45. PubMed ID: 19531574
[TBL] [Abstract][Full Text] [Related]
16. Liver X receptor agonists with selectivity for LXRbeta; N-aryl-3,3,3-trifluoro-2-hydroxy-2-methylpropionamides.
Swahn BM; Macsari I; Viklund J; Ohberg L; Sjödin J; Neelissen J; Lindquist J
Bioorg Med Chem Lett; 2009 Apr; 19(7):2009-12. PubMed ID: 19264481
[TBL] [Abstract][Full Text] [Related]
17. Discovery and optimization of a series of liver X receptor antagonists.
Jiao X; Kopecky DJ; Fisher B; Piper DE; Labelle M; McKendry S; Harrison M; Jones S; Jaen J; Shiau AK; Escaron P; Danao J; Chai A; Coward P; Kayser F
Bioorg Med Chem Lett; 2012 Sep; 22(18):5966-70. PubMed ID: 22901900
[TBL] [Abstract][Full Text] [Related]
18. Liver X receptor agonists suppress vascular smooth muscle cell proliferation and inhibit neointima formation in balloon-injured rat carotid arteries.
Blaschke F; Leppanen O; Takata Y; Caglayan E; Liu J; Fishbein MC; Kappert K; Nakayama KI; Collins AR; Fleck E; Hsueh WA; Law RE; Bruemmer D
Circ Res; 2004 Dec; 95(12):e110-23. PubMed ID: 15539633
[TBL] [Abstract][Full Text] [Related]
19. SAR studies: designing potent and selective LXR agonists.
Szewczyk JW; Huang S; Chin J; Tian J; Mitnaul L; Rosa RL; Peterson L; Sparrow CP; Adams AD
Bioorg Med Chem Lett; 2006 Jun; 16(11):3055-60. PubMed ID: 16529931
[TBL] [Abstract][Full Text] [Related]
20. The LXR agonist T0901317 promotes the reverse cholesterol transport from macrophages by increasing plasma efflux potential.
Zanotti I; Potì F; Pedrelli M; Favari E; Moleri E; Franceschini G; Calabresi L; Bernini F
J Lipid Res; 2008 May; 49(5):954-60. PubMed ID: 18252848
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]